Back to search

University of Birmingham

Investigations of DNA and anthracene as agents for drug release

Abstract

dc:description.abstract

Targeted drug release has been a strong focus in the pharmaceutical industry in recent decades in an attempt to minimise the often severe side effects observed in therapeutics. Many methods of targeted drug release look at incorporating the drug moiety into nanoparticles, but other techniques can involve an organic drug donor with an attached targeting vector. Aptamers, single stranded oligonucleotides which can fold into complex structures capable of binding to non-DNA analytes with high selectivity and specificity, have often been highlighted as possible vectors for drug delivery. This thesis aims to contribute to the field of therapeutic delivery by investigations into both organic drug donor molecules and aptamer-derived directing capabilities. The first approach of this project primarily involved the synthesis, characterisation, and study of a range of anthracene-derived nitroxyl (HNO) donors for potential therapeutics. A number of 9- and 9,10-substituted anthracene diols were designed as dienes for a Diels-Alder cycloaddition to create an HNO donating molecule capable of photo-initiated release. Further investigations into the stability of cycloadducts formed, and the conjugation of such moieties to a range of targeting vectors were attempted. Following this HNO donating theme, an anthracene-derived Piloty’s acid analogue was also prepared and its behaviour under photoirradiation investigated. In a different approach, aptamers for controlled drug capture and release were designed and investigated for reversible drug binding. By designing short segments of complementary DNA that would disrupt the secondary structure of the aptamer species, reversible binding could be demonstrated. Finally, the challenge of the Covid-19 pandemic led to the use of anthracene-modified oligonucleotides in the diagnosis of variant species of the virus. Anthracene tags were designed and synthesised, incorporated into short oligonucleotide probe strands and the fluorescence changes of the anthracene upon interaction with single base mutations of the Covid-19 spike protein genome were investigated.

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Farrow, Charlotte M. A.

Subjects

dc:subject × 1

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Farrow, Charlotte M. A.. Investigations of DNA and anthracene as agents for drug release. d_ph thesis, University of Birmingham, 2022.